Home › Duchenne Muscular Dystrophy › Tennessee
Duchenne Muscular Dystrophy clinical trials in Tennessee
5 studies for Duchenne Muscular Dystrophy are looking for participants at sites in Tennessee.
Cities in Tennessee
Glucagon-Like Peptide-1 Receptor Agonists to Attenuate Metabolic Risk in Individuals With Duchenne Muscular Dystrophy
- Vanderbilt University Medical Center, Nashville
RecruitingPhase 1/2
Ages 18 and older · Men · Updated Nov 12, 2026 · NCT07642635Study to Evaluate the Safety and Effectiveness of ELEVIDYS in Participants With Duchenne Muscular Dystrophy Treated in a Post-Marketing Setting
- Vanderbilt University Medical Center, Nashville
RecruitingPhase 4
Ages 4 and older · Men · Updated Nov 12, 2026 · NCT07542314Sodium/Glucose Cotransporter-2 Inhibitors (SGLT2i) Therapy in Duchenne Cardiomyopathy
- Vanderbilt University Medical Center, Nashville
RecruitingPhase 1
Ages 8 to 18 · Men · Updated Aug 24, 2026 · NCT07172971Modeling Mortality in Duchenne Muscular Dystrophy Cardiomyopathy: Identification of Surrogate Outcome Measures for DMD Drug Trials
- Vanderbilt University Medical Center, Nashville
RecruitingObservational study
All ages · All sexes · Updated Jul 28, 2026 · NCT07674758Wearable Technology to Evaluate Hyperglycemia and HRV in DMD
- Vanderbilt University Medical Center, Nashville
RecruitingObservational studyHealthy volunteers welcome
Ages 10 and older · Men · Updated May 22, 2026 · NCT06124196From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.